Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$162,976,296
New position
Shares Held
826,368
first reported quarter
Ownership
0.053%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OMERS ADMINISTRATION Corp holds $440,141,055 across 10 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
511,025 | $129,785,019 | |
| 2 | LLY |
ELI LILLY & Co
|
93,080 | $111,642,953 | |
| 3 | MRK |
Merck & Co., Inc.
|
547,569 | $70,362,616 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
441,303 | $55,754,221 | |
| 5 | ABBV |
AbbVie Inc.
|
134,479 | $33,840,295 | |
| 6 | AMGN |
Amgen Inc
|
37,717 | $13,658,080 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
173,350 | $9,988,427 | |
| 8 | PFE |
Pfizer Inc
|
375,974 | $9,053,453 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $162,976,296 | 826,368 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||